211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
The Readout Loud
00:00
I Saw Top Gun. It Was as Good as Youd Expect It to Be
Next week, the fda will convene a its scientific advisers to talk about two separate gean therapies from bluebiard. Each of which has had a somewhat rough and tumble path to this moment. And for that reason, i have no doubt that many people, whether scientists, patients or other companies involved in jean therapy, will be watching for what plays out with this bluebird saga.
Transcript
Play full episode
